10/21/2026
Psychedelics and Silicon Valley: A new frontier
Psychedelics shift from counterculture to tech industry darling, reshaping capitalism.
Topic archive
donald trump
40 stories
10/20/2026
Psychedelics fast-tracked by FDA under Trump order
Executive order allocates $50 million for psychedelic drug development, including ibogaine.
10/18/2026
Gabon moves to protect iboga plant from US pharmaceutical demand
Gabon bans iboga exports to safeguard cultural heritage amid rising global interest.
10/8/2026
Texas ibogaine trials face funding gap as federal support looms
Federal funds may replace private investment in Texas ibogaine research
10/8/2026
Ibogaine shows promise for PTSD relief in veterans
Study finds significant symptom improvement in PTSD, depression after ibogaine treatment.
10/6/2026
US funds ibogaine trials for opioid addiction
Trump administration allocates $50M for ibogaine research
10/6/2026
Trump explores psychedelic mental health treatments
Former President Trump reportedly interested in psychedelic therapies for mental health.
10/4/2026
Trump signs order to ease mental health treatment rules
Executive order aims to reduce barriers to mental health care access.
9/22/2026
Presley Gerber's death raises questions about ibogaine treatment
Model's overdose at Malibu rehab prompts scrutiny of ibogaine use.
9/22/2026
Ibogaine treatment and the case of Presley Gerber
Presley Gerber's use of ibogaine highlights its controversial role in addiction treatment.
9/21/2026
Ibogaine gains attention for addiction treatment
Psychedelic compound ibogaine draws interest amid regulatory shifts.
9/17/2026
Ibogaine research advances in U.S. and Israel for PTSD
Psychedelic therapies gain momentum as potential treatments for combat-related trauma.
9/15/2026
Psychedelic therapies cited by Trump: key insights
Trump's mention of psychedelic therapies sparks renewed interest in their potential applications.
8/21/2026
University of Miami gifts ibogaine application to Trump admin
The move could expedite psychedelic research for veteran treatment.
8/21/2026
Johnson & Johnson invests in Delix Therapeutics
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.
8/21/2026
Ibogaine research gains momentum for PTSD treatment
Trump administration accelerates psychedelic research for veterans' mental health.
8/20/2026
Trump's FDA pick linked to Joe Rogan-backed psychedelic policy
Dr. Heidi Overton, nominated by Trump, expedited psychedelic research policy.
8/19/2026
Ibogaine biotech stocks rise after Trump comments
University of Miami's 1994 ibogaine application resurfaces, boosting market interest.
8/19/2026
Trump's FDA pick Overton may boost psychedelics, pain meds
Heidi Overton's nomination could advance psychedelic therapies but raises vaccine concerns.
8/19/2026
Trump pushes ibogaine treatment for veterans
Trump's administration advances psychedelic therapies for PTSD and TBI in veterans.
8/19/2026
Trump supports psychedelic drugs for veterans' mental health
Former President Trump advocates for psychedelic treatment to aid veterans.
8/19/2026
Trump emphasizes ibogaine development, Psyence BioMed reacts
Former President Trump supports ibogaine research, sparking industry response.
8/19/2026
Psyence BioMed backs Trump ibogaine initiative
Company aligns with U.S. efforts to advance ibogaine research.
8/19/2026
Trump highlights ibogaine in executive order on psychedelics
The executive order aims to expedite research on ibogaine and other psychedelics.
8/19/2026
Trump highlights ibogaine research in executive order
Ibogaine, a psychedelic drug, gains federal attention for treating addiction.
8/19/2026
University of Miami submits ibogaine application to federal authorities
Trump announces transfer of ibogaine investigational drug application to accelerate research.
8/19/2026
Arizona funds $5M ibogaine study for brain injuries
Barrow Neurological Institute to explore ibogaine's potential for PTSD and brain injuries.
8/18/2026
University of Miami gifts ibogaine application to FDA
The move aims to expedite ibogaine research under a new executive order.
8/18/2026
Ibogaine's potential boosted by Trump announcement
Trump's recent statement may influence ibogaine's role in psychedelic therapy.
8/13/2026
Ibogaine gains attention as Trump discusses potential
Former President Trump highlights ibogaine in discussions on addiction.
8/7/2026
Ibogaine gains traction among conservative leaders
Rick Perry and Bryan Hubbard lead efforts to legitimize ibogaine in Texas.
7/31/2026
Congressman Luttrell champions ibogaine for PTSD treatment
Luttrell's IBOGAINE Act aims to solidify psychedelic therapy access for veterans.
7/24/2026
Heidi Overton's role in Trump's ibogaine policy
White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.
7/24/2026
Joe Rogan's ibogaine advocacy sparks White House tension
Rogan's push for ibogaine approval led to conflict with a key Trump aide.
7/24/2026
Trump administration fast-tracks ibogaine research
Psychoactive drug ibogaine gains attention for addiction treatment potential.
7/24/2026
Trump administration fast-tracks ibogaine research
Ibogaine research gains momentum under Trump administration's expedited process.
7/24/2026
Ibogaine may gain U.S. access under Trump administration
The Trump administration considers making ibogaine available for therapeutic use.
7/23/2026
Trump administration considers ibogaine for addiction treatment
Ibogaine, a psychedelic, eyed for opioid crisis intervention under Trump.
7/23/2026
Trump executive order boosts psychedelic therapy research
Order encourages psychedelic research, allocates $50M for state studies.
7/22/2026
Federal agencies advance psychedelic therapy post-Trump order
Trump's 2026 executive order boosts psychedelic research funding and collaboration.